Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial

被引:5
|
作者
Bichler, Carina S. [1 ]
Niedermeier, Martin [1 ]
Huefner, Katharina [2 ]
Galffy, Matyas [2 ]
Gostner, Johanna M. [3 ]
Nelles, Philipp [2 ]
Schoettl, Stefanie E. [1 ]
Sperner-Unterweger, Barbara [2 ]
Kopp, Martin [1 ]
机构
[1] Univ Innsbruck, Dept Sport Sci, Fuerstenweg 185, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Univ Hosp Psychiat 2, Dept Psychiat Psychotherapy Psychosomat & Med Psy, Anichstr 35, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Inst Med Biochem, Bioctr, Innrain 80-82, A-6020 Innsbruck, Austria
关键词
anxiety disorder; post-traumatic stress disorder; exercise; physical activity; climbing therapy; biomarker; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; PHYSICAL-ACTIVITY; SERUM TRYPTOPHAN; NORDIC WALKING; EXERCISE; PEOPLE; HEALTH; METAANALYSIS;
D O I
10.3390/ijerph191811622
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Exercise has considerable effects on physical and psychological health. Anxiolytic effects of climbing exercise have been found in people suffering from depression. However, there are no studies on patients with severe anxiety disorders or post-traumatic stress disorder (PTSD) practicing climbing as add-on treatment. Additionally, many studies on physical therapy fail to use adequate active control groups. Therefore, this study aimed to investigate the feasibility of a four-week climbing exercise program for patients with anxiety disorders or PTSD in comparison to a standard exercise treatment and a social control group. Methods: Outpatients diagnosed with anxiety disorders or PTSD (F 40, F 41, F 43.1 according to ICD-10) were randomly assigned to (a) climbing exercise (n = 27), (b) Nordic walking exercise (n = 23), or (c) control condition (n = 23) providing the same amount of social contact for eight sessions of 90 minutes each. Psychological parameters (symptom severity, worry symptoms, self-efficacy, quality of life) and biological parameters were assessed at the beginning and at the end of the four-week program. Additionally, follow-up assessments were conducted three and six months after the program ended. Results: Sixty outpatients (75% female) aged 18-65 years with a longstanding history of a mental disorder (>10 years) and classified as treatment-resistant (95%) and with averaging 3.8 psychiatric comorbidities completed the pilot trial. After participation, symptoms of anxiety disorders were significantly reduced (p = 0.003), and health-related characteristics significantly improved (depression symptoms: p < 0.001, worry symptoms: p < 0.001, self-efficacy: p < 0.001, quality of life-physical health: p = 0.002, quality of life-psychological health: p = 0.006) in all groups. The feasibility of conducting climbing exercises for the patient groups could be demonstrated, and a general acceptance in the groups was recorded. No significant time-by-group interactions were found. At the completion of the program, psychological parameters improved, while biological parameters remained the same in all three groups. Conclusions: Participation in the climbing group as well as in Nordic walking and social contact groups demonstrated beneficial results in patients with anxiety disorders and PTSD with severe mental burden. Nevertheless, climbing did not show any additional clinically relevant benefits compared to Nordic walking or social contact. Studies with larger sample sizes and qualitative insights are needed to further evaluate the possible benefits of climbing in this population.
引用
收藏
页数:18
相关论文
共 49 条
  • [21] Cost-Utility Analysis of Routine Anxiety and Depression Screening in Patients Consulting for Osteoarthritis: Results From a Clinical, Randomized Controlled Trial
    Kigozi, Jesse
    Jowett, Sue
    Nicholl, Barbara I.
    Lewis, Martyn
    Bartlam, Bernadette
    Green, Daniel
    Belcher, John
    Clarkson, Kris
    Lingard, Zoe
    Pope, Christopher
    Chew-Graham, Carolyn A.
    Croft, Peter
    Hay, Elaine M.
    Peat, George
    Mallen, Christian D.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (12) : 1787 - 1794
  • [22] Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial
    Ghielen, Ires
    van Wegen, Erwin E. H.
    Rutten, Sonja
    de Goede, Cees J. T.
    Houniet-de Gier, Marieke
    Collette, Emma H.
    Burgers-Bots, Ingrid A. L.
    Twisk, Jos W. R.
    Kwakkel, Gert
    Vermunt, Kees
    van Vliet, Bep
    Berendse, Henk W.
    van den Heuvel, Odile A.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2017, 103 : 1 - 8
  • [23] RETRACTION: The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders (Retraction of Vol 11, art no 24282, 2021)
    Parfenov, Vladimir Anatolevich
    Kamchatnov, Pavel Rudolfovich
    Khasanova, Dina Rustemovna
    Bogdanov, Enver Ibragimovich
    Lokshtanova, Tatiana Markovna
    Amelin, Aleksandr Vitalevich
    Maslova, Natalya Nikolaevna
    Pizova, Nataliia Vyacheslavovna
    Belskaya, Galina Nikolaevna
    Barantsevich, Evgeny Robertovich
    Duchshanova, Gulsum Abdurahmanovna
    Kamenova, Saltanat Ualihanovna
    Kolokolov, Oleg Vladimirovich
    Glazunov, Alexey Borisovich
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) Add-On Therapy to a Standard Treatment in Individuals with Multiple Sclerosis and Concomitant Symptoms of Depression-Results from a Randomized Clinical Trial and Pilot Study
    Ahmadpanah, Mohammad
    Amini, Shiva
    Mazdeh, Mehrdokht
    Haghighi, Mohammad
    Soltanian, Alireza
    Jahangard, Leila
    Keshavarzi, Amir
    Brand, Serge
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [25] Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial
    Hanania, Nicola A.
    Boota, Ahmad
    Kerwin, Edward
    Tomlinson, LaTanya
    Denis-Mize, Kimberly
    DRUGS, 2009, 69 (09) : 1205 - 1216
  • [26] A randomized controlled trial comparing conservative versus surgical treatment in patients with foot drop due to peroneal nerve entrapment: results of an internal feasibility pilot study
    Oosterbos, Christophe
    Rummens, Sofie
    Bogaerts, Kris
    Van Hoylandt, Anais
    Hoornaert, Sophie
    Weyns, Frank
    Dubuisson, Annie
    Ceuppens, Jeroen
    Schuind, Sophie
    Groen, Justus L.
    Lemmens, Robin
    Theys, Tom
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [27] A randomized controlled trial comparing conservative versus surgical treatment in patients with foot drop due to peroneal nerve entrapment: results of an internal feasibility pilot study
    Christophe Oosterbos
    Sofie Rummens
    Kris Bogaerts
    Anaïs Van Hoylandt
    Sophie Hoornaert
    Frank Weyns
    Annie Dubuisson
    Jeroen Ceuppens
    Sophie Schuind
    Justus L Groen
    Robin Lemmens
    Tom Theys
    Pilot and Feasibility Studies, 9
  • [28] An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial
    Mohammadi-Araghi, Maryam
    Eslaminejad, Alireza
    Karegar-Borzi, Hossein
    Mazloomzadeh, Saeideh
    Nejatbakhsh, Fatemeh
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [29] Evaluating efficacy and safety of Saffron add-on treatment in improvement of motor and depressive symptoms of patients with Parkinson's disease: A randomized, double-blind, placebo-controlled clinical trial
    Lalezari, Vahirezad
    Aghamollaii, Vajiheh
    Moslehi, Ahmadreza
    Najafi, Amir
    Parsaei, Mohammadamin
    Beikmarzehei, Alireza
    Moghaddam, Hossein Sanjari
    Abdolghaffari, Amir Hossein
    Akhondzadeh, Shahin
    JOURNAL OF HERBAL MEDICINE, 2024, 48
  • [30] Effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders on quality of life, symptoms, and empowerment: results of a randomized controlled trial
    Maringa H. H. Zoun
    Bauke Koekkoek
    Henny Sinnema
    Christina M. van der Feltz-Cornelis
    Anton J. L. M. van Balkom
    Aart H. Schene
    Filip Smit
    Jan Spijker
    BMC Psychiatry, 19